
    
      80 children and adolescents (4-16 years) with biopsy-proven NASH will be enrolled. They will
      be randomized to treatment with hydroxytyrosol and vitamin E (n: 40 pts) or an identical
      placebo (n: 40 pts) given orally for a period of 16 weeks. Patients will undergo a medical
      evaluation at baseline (enrollment) and after 4 months (end of treatment). Anthropometric
      measures and laboratory assay, includin liver enzymes, gluco-insulinemic and lipid profiles
      will be performed at baseline and at the end of the study. Hepatic ultrasound examination
      will be performed at enrollment and at the end of the study.

      Serum sample for determination of markers of inflammation and oxidative stress will be
      collected at enrollment and at the end of the study.

      A stool sample for analysis of gut microbioma will be collected at enrollment and at the end
      of the study.
    
  